what are the Recommendations for Cardio-Oncology
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In asymptomatic patients with cancer therapy? related cardiomyopathy (EF <50%), ARB, ACEi, and beta blockers are reasonable to prevent progression to HF and improve cardiac function.